多重插补提升高维药物基因组学基因型插补:机器学习方法评估
该研究基于药代动力学结核模拟与1000基因组计划SNP数据,比较机器学习与传统插补及协变量选择方法,并开发整合基因型概率、插补不确定性(INFO评分)和缺失百分比的多重插补框架。模拟中仅多重插补使95%置信区间覆盖真实值的比例超过90%名义阈值,例如插补服务器上10%缺失时覆盖从单插补的0%提升至94%。应用于华法林临床数据集和UK Biobank,多重插补恢复已知药物基因组关联、减少假阳性并检测单插补遗漏的信号,计算成本增加有限。
要点
- 多重插补在模拟中达到超过90%的95%置信区间覆盖,单插补覆盖不足。
- 在华法林和UK Biobank数据中恢复CYP2C9*8/*9/*11与VKORC1 -1639G>A关联。
- 多重插补检测到单插补遗漏的全基因组显著信号rs4697699(SLC2A9位点)。
核心结论
- 多重插补提高高维药物基因组学插补可靠性与发现能力,机器学习在SNP选择中益处不一致。
研究设计与样本
- 使用药代动力学结核模拟和1000基因组计划SNP数据比较机器学习与传统插补及协变量选择方法。
- 开发整合基因型概率、INFO评分和缺失百分比的多重插补框架,并采用降维实现随机森林和惩罚回归。
- 应用于华法林临床数据集War-PATH(n=548)和IWPC(n=316)以及UK Biobank(n=500, 1000)。
主要发现
- 模拟中仅多重插补达到超过90%名义阈值的95%置信区间覆盖,插补服务器上10%缺失时覆盖从单插补0%提升至94%。
- 在华法林和UK Biobank数据中恢复CYP2C9*8/*9/*11和VKORC1 -1639G>A关联,减少假阳性。
- 检测到单插补遗漏的全基因组显著信号rs4697699(SLC2A9位点)。
- SNP选择中惩罚回归在高效应场景表现最佳(F1=0.897±0.091),GWAS后随机森林在低效应场景最佳(F1=0.657±0.110)。
- 计算成本适度,在Michigan Imputation Server上10次插补仅比单插补22.7分钟增加约1.25分钟。
临床怎么用
- 在高维药物基因组学插补中优先考虑多重插补以改善置信区间覆盖和关联发现。
- SNP选择可依据效应场景选择惩罚回归或GWAS后随机森林,但机器学习益处不一致需谨慎评估。
局限性
- 研究结果超越所研究数据集的普适性有限。
- 计算可扩展性至更大生物样本库规模分析仍需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Multiple imputation is well-established for handling missing data, yet its use in high-dimensional genetic datasets remains limited. Using pharmacokinetic tuberculosis simulations and SNP data (1000 Genomes Project), we compared machine learning (ML) and traditional approaches (e.g., mean imputation and complete-case analysis) for imputation and covariate selection. We developed a multiple imputation framework incorporating genotype probabilities, imputation uncertainty (INFO score), and missingness percentages. Dimensionality reduction enabled scalable random forest and penalized regression for covariate selection. In simulations, only multiple imputation achieved adequate coverage (percentage of 95% confidence intervals containing the true value) exceeding a 90% nominal threshold. For example, on the imputation server, coverage improved from 0% with single imputation to up to 94% under 10% missingness. Applied to clinical warfarin datasets (War-PATH, n = 548; IWPC, n = 316) and the UK Biobank (n = 500, 1000), multiple imputation recovered known pharmacogenomic associations (CYP2C9*8/*9/*11; VKORC1 -1639G>A), reduced false-positives, and detected signals missed by single imputation (e.g., genome-wide significant rs4697699, SLC2A9 locus). Computational costs were modest, adding only ~1.25 minutes for 10 imputations to the 22.7 minutes required by single imputation on the Michigan Imputation Server. For SNP selection, penalized regression performed best in the high-effect scenario (F1 = 0.897 ± 0.091), while GWAS followed by random forest performed best in the low-effect scenario (F1 = 0.657 ± 0.110). These findings show that multiple imputation improves reliability and discovery in high-dimensional pharmacogenomics, with ML offering promising but inconsistent benefits during SNP selection. However, generalizability beyond the studied datasets and computational scalability to larger biobank-scale analyses remain important limitations that warrant further investigation.
引用
- Asiimwe IG, You T, Carr DF, et al. Improving Genotype Imputation in High-Dimensional Pharmacogenomics Using Multiple Imputation: Evaluation with Machine Learning Approaches. Clin Pharmacol Ther. 2025. PMID: 41407383. doi:10.1002/cpt.70171
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。